| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 886,000 | 2,969,000 | 2,245,000 | 2,273,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 2,969,000 | 2,245,000 | 2,273,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,835,000 | 1,897,000 | 2,291,000 | 2,778,000 | | Non Recurring | (1,000) | (1,000) | 603,000 | 218,000 | | Others | (1,062,000) | 1,062,000 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (16,000) | 11,000 | (649,000) | (723,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 114,000 | 11,000 | (649,000) | (723,000) | | Interest Expense | 69,000 | 61,000 |
-
| 72,000 | | Income Before Tax | 45,000 | (50,000) | (649,000) | (795,000) | | Income Tax Expense | (27,000) | (44,000) | (70,000) | (290,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 72,000 | (6,000) | (579,000) | (505,000) | | | Non-recurring Events | | Discontinued Operations | 81,000 | (155,000) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 153,000 | (161,000) | (579,000) | (505,000) | | Preferred Stock And Other Adjustments | (16,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $137,000 | ($161,000) | ($579,000) | ($505,000) |
|
1.52% Nasdaq 0.00%
Income Statement
